Cystic fibrosis (CF)
206 results
101 - 200
Pancreatic enzyme replacement therapy for people with cystic fibrosis- Psychological interventions for individuals with cystic fibrosis and their families
- Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis
- Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis
- Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
- Short‐acting inhaled bronchodilators for cystic fibrosis
- Probiotics for people with cystic fibrosis
- Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis
- Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis
- Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis
- Macrolide antibiotics (including azithromycin) for cystic fibrosis
- Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
- Non-invasive ventilation for cystic fibrosis: Cochrane systematic review
- Vitamin D supplementation for cystic fibrosis
- Physical therapies for postural abnormalities in people with cystic fibrosis
- Recombinant growth hormone therapy for cystic fibrosis in children and young adults
- Bisphosphonates for osteoporosis in people with cystic fibrosis
- Long‐acting inhaled bronchodilators for cystic fibrosis
- Ursodeoxycholic acid for cystic fibrosis‐related liver disease
- Surgery for nasal polyposis in cystic fibrosis
- Prophylactic anti‐staphylococcal antibiotics for cystic fibrosis
- Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis
- Insulin and oral agents for managing cystic fibrosis‐related diabetes
- Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
- Duration of intravenous antibiotic therapy in people with cystic fibrosis
- Antioxidant supplementation for lung disease in cystic fibrosis
- Bronchoscopy‐guided antimicrobial therapy for cystic fibrosis
Pancreatic insufficiency - Dornase alfa for cystic fibrosis
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis‐related lung disease
- Nebuliser systems for drug delivery in cystic fibrosis
- Digital technology for early identification of exacerbations in people with cystic fibrosis
- Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis
- Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
- Physical activity and exercise training in cystic fibrosis
- Disease modifying anti‐rheumatic drugs in people with cystic fibrosis‐related arthritis
- Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
- Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
- Interventions for promoting physical activity in people with cystic fibrosis
- Exercise versus airway clearance techniques for people with cystic fibrosis
- Active cycle of breathing technique for cystic fibrosis
- Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults
- Interventions for promoting participation in shared decision‐making for children and adolescents with cystic fibrosis
- Autogenic drainage for airway clearance in cystic fibrosis
- Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews
- Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis
- Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
- Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
- Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis
- Self‐management education for cystic fibrosis
- Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis
- Inhaled bronchodilators for cystic fibrosis: Cochrane systematic review
- Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
- Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
- Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
- Nebulised hypertonic saline for cystic fibrosis
- Appetite stimulants for people with cystic fibrosis
- Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis
- Inhaled mannitol for cystic fibrosis
- Oral steroids for long‐term use in cystic fibrosis
- Prolonged cough in a child